ACVR2A Antibody (N-term) Blocking Peptide
€293.00
In stock
SKU
AC-BP7103a
Background:
ACVR2A is an activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.
Other Names: Activin receptor type-2A, Activin receptor type IIA, ACTR-IIA, ACTRIIA, ACVR2A, ACVR2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7103a was selected from the N-term region of human ACVR2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P27037
Gene ID: 92
Gene Name: ACVR2A
Format: The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Bio References:
Jung, B., et al., Gastroenterology 126(3):654-659 (2004).Martins da Silva, S.J., et al., Dev. Biol. 266(2):334-345 (2004).Olaru, A., et al., Lab. Invest. 83(12):1867-1871 (2003).Casagrandi, D., et al., Mol. Hum. Reprod. 9(4):199-203 (2003).Greenwald, J., et al., Mol. Cell 11(3):605-617 (2003).
ACVR2A is an activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.
Other Names: Activin receptor type-2A, Activin receptor type IIA, ACTR-IIA, ACTRIIA, ACVR2A, ACVR2
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7103a was selected from the N-term region of human ACVR2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P27037
Gene ID: 92
Gene Name: ACVR2A
Format: The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
Bio References:
Jung, B., et al., Gastroenterology 126(3):654-659 (2004).Martins da Silva, S.J., et al., Dev. Biol. 266(2):334-345 (2004).Olaru, A., et al., Lab. Invest. 83(12):1867-1871 (2003).Casagrandi, D., et al., Mol. Hum. Reprod. 9(4):199-203 (2003).Greenwald, J., et al., Mol. Cell 11(3):605-617 (2003).
| Is Featured? | No |
|---|
Write Your Own Review